NCT04057924Recruiting
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
Source: ClinicalTrials.gov · Last updated 10 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study proposes to describe and evaluate the rate of spontaneous regression of CIN2 at 2 year of follow up in women between 18 and 39 year old. This follow-up is proposed as an alternative to the treatment of reference (conization) with a possible extension to 4 years
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 4 Jul 2019
- Start date
- 23 Aug 2019
- Primary completion date
- 1 Sept 2029
- Lead sponsor
- University Hospital, Bordeaux
- Diseases
- Cervical cancer
- NCT number
- NCT04057924
What you commit to
- Study type: Observational
- Planned participants: 200
- From 23 Aug 2019 to the primary completion date, 1 Sept 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- long-term treatment with corticosteroids or immunosuppressants, placement under safeguard of justice,
Other illness
- history of conization,
- atypical or atypical glandular cells or cancer incidentally discovered during smear,
- active systemic infection requiring treatment, history of HIV infection, congenital or acquired immunodepression,
Other
- Pregnancy in progress,
- prophylactic vaccination against HPV,
- non-compliance with protocol requirements, in particular a supposed lack of compliance with long-term follow-up
Who the study is looking for
- CIN2 confirmed by biopsy, age between 18 and 39 years,
- satisfactory colposcopy identifying the junction and the lesion,
- affiliated person or beneficiary of a social security scheme,
- having given their oral agreement and authorization to the processing of their data.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Bordeaux Coordinator of this site? Confirm its status | Bordeaux | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.